Top

Published in:

01-04-2018 | Original Article

The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation

Authors: Madeline L. O’Sullivan, Rebecca A. Shelby, Caroline S. Dorfman, Sarah A. Kelleher, Hannah M. Fisher, Krista A. Rowe Nichols, Francis J. Keefe, Anthony D. Sung, Tamara J. Somers

Published in: Supportive Care in Cancer | Issue 4/2018

Abstract

Purpose

Pain is common for hematopoietic stem cell transplant (HSCT) patients and may be experienced pre-transplant, acutely post-transplant, and for months or years following transplant. HSCT patients with persistent pain may be at risk for poor quality of life following transplant; however, the impact of pre-transplant pain on quality of life post-transplant is not well understood. Self-efficacy for chronic disease management is associated with quality of life among cancer patients and may impact quality of life for HSCT patients. The primary aim was to examine the effect of pre-transplant pain and self-efficacy on quality of life domains in the year following transplant.

Methods

One hundred sixty-six HSCT patients completed questionnaires providing information on pain, self-efficacy, and quality of life prior to transplant, at discharge, and 3-, 6-, and 12-months post-transplant as part of a longitudinal, observational study. Linear mixed modeling examined the trajectories of these variables and the effect of pre-transplant pain and self-efficacy on post-transplant quality of life.

Results

Pain and social and emotional quality of life remained stable in the year following transplant while self-efficacy and physical and functional quality of life improved. Pre-transplant pain was significantly related to lower physical well-being post-transplant. Lower pre-transplant self-efficacy was related to lower quality of life across all domains post-transplant.

Conclusion

Above and beyond the effect of pre-transplant pain, self-efficacy for managing chronic disease is important in understanding quality of life following transplant. Identifying patients with pain and/or low self-efficacy pre-transplant may allow for early intervention with self-management strategies.

Bhatia S, Ramsay NKC, Robison LL, Snyder D, Stein A, Forman SJ, Weisdorf DJ, Francisco L, Carter A, Sun C-L, Baker KS, Gurney JG, McGlave PB, Nademanee A, O'Donnell M (2007) Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110(10):3784–3792. https://doi.org/10.1182/blood-2007-03-082933 CrossRefPubMedPubMedCentral

Cutler C (2017) The approach to hematopoietic cell transplantation survivorship. UpToDate, UpToDate, Waltham, MA

Champlin R (2003) Selection of autologous or allogeneic transplantation. In: Kufe DW, Pollock RE, Weischselbaum RR et al (eds) Cancer medicine, 6th edn. BC Decker, Hamilton, ON

Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN (2009) Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psycho-Oncology 18(2):113–127. https://doi.org/10.1002/pon.1399 CrossRefPubMedPubMedCentral

Niscola P, Romani C, Scaramucci L, Dentamaro T, Cupelli L, Tendas A, Piccioni D, Giovannini M, Tolu B, Cartoni C, Arcuri E, Perrotti A, Palumbo R, de Fabritiis P (2008) Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies. Bone Marrow Transplant 41 (9):757–764

Frodin U, Lotfi K, Fomichov V, Juliusson G, Borjeson S (2015) Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation. Eur J Cancer Care (Engl) 24(6):898–910. https://doi.org/10.1111/ecc.12350 CrossRef

Reinfjell T, Tremolada M, Zeltzer LK (2017) A review of demographic, medical, and treatment variables associated with health-related quality of life (HRQOL) in survivors of hematopoietic stem cell (HSCT) and bone marrow transplantation (BMT) during childhood. Front Psychol 8:253. https://doi.org/10.3389/fpsyg.2017.00253 CrossRefPubMedPubMedCentral

Byar KL, Eilers JE, Nuss SL (2005) Quality of life 5 or more years post-autologous hematopoietic stem cell transplant. Cancer Nurs 28(2):148–157. https://doi.org/10.1097/00002820-200503000-00010 CrossRefPubMed

Jim HSL, Sutton SK, Jacobsen PB, Martin PJ, Flowers ME, Lee SJ (2016) Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation. Cancer 122(8):1290–1297. https://doi.org/10.1002/cncr.29877 CrossRefPubMed

10.

Gruber U, Fegg M, Buchmann M, Kolb HJ, Hiddemann W (2003) The long-term psychosocial effects of haematopoetic stem cell transplantation. Europe J Cancer Care 12(3):249–256. https://doi.org/10.1046/j.1365-2354.2003.00411_2.x

11.

Anderson KO, Giralt SA, Mendoza TR, Brown JO, Neumann JL, Mobley GM, Wang XS, Cleeland CS (2007) Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant 39(12):759–766. https://doi.org/10.1038/sj.bmt.1705664 CrossRefPubMed

12.

Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A, Höcker P, Dieckmann K, Fischer G, Rosenmayr A, Linkesch W, Hinterberger W, Lechner K, Greinix HT (2002) Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 30(9):619–626. https://doi.org/10.1038/sj.bmt.1703677 CrossRefPubMed

13.

Bandura A (1997) Self-efficacy : The exercise of control: The exercise of control, vol Book, Whole. W.H. Freeman, New York

14.

Hochhausen N, Altmaier EM, McQuellon R, Davies SM, Papadopolous E, Carter S, Henslee-Downey J (2007) Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation. J Psychosoc Oncol 25(1):87–101. https://doi.org/10.1300/J077v25n01_05 CrossRefPubMed

15.

Hoffman AJ (2013) Enhancing self-efficacy for optimized patient outcomes through the theory of symptom self-management. Cancer Nurs 36(1):E16–E26. https://doi.org/10.1097/NCC.0b013e31824a730a CrossRefPubMedPubMedCentral

16.

Smith SR, Hobson ME, Haig AJ (2016) Distress prior to undergoing hematopoietic stem cell transplantation: demographic and symptom correlations and establishing a baseline. Patient Relat Outcome Meas 7:137–144. https://doi.org/10.2147/PROM.S109877 CrossRefPubMedPubMedCentral

17.

Jerant A, Franks P, Kravitz RL (2011) Associations between pain control self-efficacy, self-efficacy for communicating with physicians, and subsequent pain severity among cancer patients. Patient Educ Couns 85(2):275–280. https://doi.org/10.1016/j.pec.2010.11.007 CrossRefPubMed

18.

Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M (2001) Effect of a self-management program on patients with chronic disease. Effect Clin Pract 4(6):256–262

19.

Somers TJ, Shelby RA, Keefe FJ, Godiwala N, Lumley MA, Mosley-Williams A, Rice JR, Caldwell D (2010) Disease severity and domain-specific arthritis self-efficacy: relationships to pain and functioning in patients with rheumatoid arthritis. Arthritis Care Res 62(6):848–856. https://doi.org/10.1002/acr.20127 CrossRef

20.

Cleeland CS (ed) (1989) Measurement of pain by subjective report, vol 12. Issues in Measurement. Raven Press, New York

21.

Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its inference with function. Pain 61:277–284CrossRefPubMed

22.

Lorig K, Chastain RL, Ung E, Shoor S, Holman HR (1989) Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum 32(1):37–44. https://doi.org/10.1002/anr.1780320107 CrossRefPubMed

23.

McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A, Hurd DD (1997) Quality of life measurement in bone marrow transplantation: development of the functional assessment of cancer therapy-bone marrow transplant (FACT-BMT) scale. Bone Marrow Transplant 19(4):357–368. https://doi.org/10.1038/sj.bmt.1700672 CrossRefPubMed

24.

Cella D (1997) Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system. Centre on Outcomes, Research and Education. Northwestern Healthcare and Northwestern University, Evanston

25.

Raudenbush SW, Bryk AS (2002) Hierarchical linear models: applications and data analysis methods: Applications and data analysis methods, vol 1., vol Book, Whole. Sage Publications, Thousand Oaks

26.

Singer JD, Willett JB (2003) Applied longitudinal data analysis: modeling change and event occurrence: modeling change and event occurrence. vol Book, Whole. Oxford University Press, New YorkCrossRef

27.

Bevans M (2010) Health-related quality of life following allogeneic hematopoietic stem cell transplantation. Hematol Am Soc Hematol Educ Program 2010:248–254. https://doi.org/10.1182/asheducation-2010.1.248

28.

Andrykowski MA, Greiner CB, Altmaier EM, Burish TG, Antin JH, Gingrich R, McGarigle C, Henslee-Downey PJ (1995) Quality of life following bone marrow transplantation: findings from a multicentre study. Br J Cancer 71(6):1322–1329CrossRefPubMedPubMedCentral

29.

Pidala J, Anasetti C, Jim H (2009) Quality of life after allogeneic hematopoietic cell transplantation. Blood 114(1):7–19. https://doi.org/10.1182/blood-2008-10-182592 CrossRefPubMedPubMedCentral

30.

McQuellon RP, Russell GB, Rambo TD, Craven BL, Radford J, Perry JJ, Cruz J, Hurd DD (1998) Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year. Bone Marrow Transplant 21(5):477–486. https://doi.org/10.1038/sj.bmt.1701115 CrossRefPubMed

31.

Sherman AC, Simonton S, Latif U, Plante TG, Anaissie EJ (2009) Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biol Blood Marrow Transplant 15(1):12–20. https://doi.org/10.1016/j.bbmt.2008.09.023 CrossRefPubMed

32.

Hjermstad MJ, Evensen SA, Kvaloy SO, Fayers PM, Kaasa S (1999) Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. J Clin Oncol 17(2):706–718. https://doi.org/10.1200/jco.1999.17.2.706 CrossRefPubMed

33.

Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW, Kemmler G, Sperner-Unterweger B (2000) EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: A comparison. Eur J Haematol 65(2):97–103CrossRefPubMed

34.

35.

Logue M, Savani BN (2013) Understanding basic steps to hematopoietic stem cell transplantation evaluation. Am J Blood Res 3(2):102–106PubMedPubMedCentral

36.

Lorig KR, Holman H (2003) Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med 26(1):1–7CrossRefPubMed

37.

Larson JL, Covey MK, Kapella MC, Alex CG, McAuley E (2014) Self-efficacy enhancing intervention increases light physical activity in people with chronic obstructive pulmonary disease. Int J Chronic Obstruct Pulmon Dis 9:1081–1090. https://doi.org/10.2147/COPD.S66846 CrossRef

38.

Somers TJ, Abernethy AP, Edmond SN, Kelleher SA, Wren AA, Samsa GP, Keefe FJ (2015) A pilot study of a mobile health pain coping skills training protocol for patients with persistent cancer pain. J Pain Symptom Manag (0). doi:https://doi.org/10.1016/j.jpainsymman.2015.04.013

39.

Somers TJ, Kelleher SA, Westbrook KW, Kimmick GG, Shelby RA, Abernethy AP, Keefe FJ (2016) A small randomized controlled pilot trial comparing mobile and traditional pain coping skills training protocols for cancer patients with pain. Pain Res Treat 2016:2473629. https://doi.org/10.1155/2016/2473629 PubMedPubMedCentral

40.

Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Frassoni F, Bacigalupo A (2000) Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 110 (3):614–619. doi:https://doi.org/10.1046/j.1365-2141.2000.02053.x

41.

Rajkumar SV (2017) Autologous hematopoietic cell transplantation in multiple myeloma. UpToDate, UpToDate, Waltham, MA

42.

Terpos E, Berenson J, Raje N, Roodman GD (2014) Management of bone disease in multiple myeloma. Expert Rev Hematol 7(1):113–125. https://doi.org/10.1586/17474086.2013.874943 CrossRefPubMed

43.

Mols F, Oerlemans S, Vos AH, Koster A, Verelst S, Sonneveld P, van de Poll-Franse LV (2012) Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 89 (4):311–319. doi:https://doi.org/10.1111/j.1600-0609.2012.01831.x

44.

Niscola P, Scaramucci L, Romani C, Giovannini M, Tendas A, Brunetti G, Cartoni C, Palumbo R, Vischini G, Siniscalchi A, Pd F, Caravita T (2010) Pain management in multiple myeloma. Expert Rev Anticancer Ther 10(3):415–425. https://doi.org/10.1586/era.10.5 CrossRefPubMed

45.

Poulos AR, Gertz MA, Pankratz VS, Post-White J (2001) Pain, mood disturbance, and quality of life in patients with multiple myeloma. Oncol Nurs Forum 28(7):1163–1171PubMed

Title: The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation
Authors: Madeline L. O’Sullivan
Rebecca A. Shelby
Caroline S. Dorfman
Sarah A. Kelleher
Hannah M. Fisher
Krista A. Rowe Nichols
Francis J. Keefe
Anthony D. Sung
Tamara J. Somers
Publication date: 01-04-2018
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 4/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-017-3947-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2018

The distress thermometer in survivors of gynaecological cancer: accuracy in screening and association with the need for person-centred support

Unpredictable episodic breathlessness in patients with advanced chronic obstructive pulmonary disease and lung cancer: a qualitative study

Unmet support needs of sexual and gender minority breast cancer survivors

Meta-ethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia

Who is a survivor? Perceptions from individuals who experienced pediatric cancer and their primary support persons

Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer